A Study to Assess the Use of Artificial Intellignce to Predict Eye Treatment Changes in Adult Participants With Diabetic Macular Edema

Inclusion Criteria: * Previously untreated Diabetic macular edema (DME) Participants. * Baseline macular edema ≥350 microns confirmed on Spectralis Standard deviation (SD)-Optical coherence tomography (OCT) or equivalent. * Baseline Best corrected visual acuity (BCVA) between 23 and 78 Early treatment diabetic retinopathy study (ETDRS) letters (between 20/32 and 20/230 Snellen). Exclusion Criteria: * History of eyes with previous intravitreal or laser treatment for DME. * History of eyes with previous intraocular or periocular corticosteroid for DME. * History eyes with other macular disease, causing visual reduction or disturbance.